Literature DB >> 16873327

Osteonecrosis of the jaw and oral bisphosphonate treatment.

John B Nase1, Jon B Suzuki.   

Abstract

BACKGROUND: Bisphosphonates are becoming recognized increasingly as having a significant impact on dental therapies. This case report describes adverse clinical sequelae and successful treatment following periodontal surgery in a dental patient receiving bisphosphonate treatment. CASE DESCRIPTION: A 78-year-old woman experienced a nonhealing interproximal wound subsequent to a minor periodontal procedure performed to facilitate restoration of an adjacent tooth. Her medical history revealed that she had been taking an oral bisphosphonate every day for the previous five years for treatment of osteoporosis. After three months of periodic débridement and meticulous oral home care, one of the authors recovered a large piece of necrotic bone. The wound healed after the author performed surgery at the site. CLINICAL IMPLICATIONS: Dentists should exercise caution when considering surgical procedures for patients with a history of oral bisphosphonate use. Thorough treatment of nonhealing wounds in these patients can lead to favorable outcomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873327     DOI: 10.14219/jada.archive.2006.0350

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  17 in total

1.  Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.

Authors:  Minju Song; Abdullah Alshaikh; Terresa Kim; Sol Kim; Michelle Dang; Shebli Mehrazarin; Ki-Hyuk Shin; Mo Kang; No-Hee Park; Reuben H Kim
Journal:  J Endod       Date:  2016-09-13       Impact factor: 4.171

2.  Legal liability in bisphosphonate-related osteonecrosis of the jaw.

Authors:  L Lo Russo; D Ciavarella; C Buccelli; O Di Fede; G Campisi; L Lo Muzio; G Pellegrino; P Di Lorenzo
Journal:  Br Dent J       Date:  2014-09       Impact factor: 1.626

Review 3.  Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.

Authors:  Giuseppe Ficarra; Francesco Beninati
Journal:  Head Neck Pathol       Date:  2007-12-05

4.  Bisphosphonate - related osteonecrosis of the jaws: the point of view of the oral pathologist.

Authors:  Giuseppe Ficarra; Francesco Beninati
Journal:  Clin Cases Miner Bone Metab       Date:  2007-01

5.  Tooth extraction in osteoporotic patients taking oral bisphosphonates.

Authors:  M Mozzati; V Arata; G Gallesio
Journal:  Osteoporos Int       Date:  2013-01-04       Impact factor: 4.507

Review 6.  Factors associated with osteonecrosis of the jaw among bisphosphonate users.

Authors:  Lisa M Hess; Joanne M Jeter; Marge Benham-Hutchins; David S Alberts
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

7.  Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases.

Authors:  W Park; N-K Kim; M-Y Kim; Y-M Rhee; H J Kim
Journal:  Osteoporos Int       Date:  2009-05-30       Impact factor: 4.507

8.  Hepatotoxicity induced by alendronate therapy.

Authors:  B Yanik; C Turkay; H Atalar
Journal:  Osteoporos Int       Date:  2007-01-17       Impact factor: 5.071

9.  Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.

Authors:  Alberto Borgioli; Christian Viviani; Marco Duvina; Leila Brancato; Giuseppe Spinelli; Maria Luisa Brandi; Paolo Tonelli
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

10.  Chemical IN04 Inhibits the Kinase Domain not the ROC Domain of LRRK1: Results from Homology Modeling and Molecular Docking.

Authors:  Zhenhang Chen; Weirong Xing; Li Fan
Journal:  Med Chem       Date:  2021       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.